Close Menu

NEW YORK (GenomeWeb) – Bio-Rad Laboratories has received clearance from the US Food and Drug Administration for its first liquid biopsy assay and Droplet Digital PCR system for diagnostic use, the firm announced today.

The test is designed for monitoring treatment response in chronic myeloid leukemia and is also the first-ever digital PCR product to receive FDA clearance, according to the company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.